• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用气相色谱 - 质谱碎片分析法对血浆白消安进行常规分析。

Routine analysis of plasma busulfan by gas chromatography-mass fragmentography.

作者信息

Lai W K, Pang C P, Law L K, Wong R, Li C K, Yuen P M

机构信息

Department of Chemical Pathology, the Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong.

出版信息

Clin Chem. 1998 Dec;44(12):2506-10.

PMID:9836718
Abstract

Busulfan (BU) is a widely used alkylating agent for antineoplastic therapy and marrow ablation in preparation for bone marrow transplantation (BMT). High-dose BU often leads to successful preparation and low relapse but is associated with veno-occlusive disease of liver. We established a protocol to determine postdosage plasma BU concentrations by gas chromatography-mass fragmentography in an attempt to relate clinical outcome to plasma BU concentrations. We used nonisotopic pusulfan as the internal standard. After extraction into ethyl acetate, BU and pusulfan were iodinated into 1, 4-diiodobutane and 1,5-diiodopentane, respectively. Gas chromatography-mass spectrometry (GC-MS) analysis was carried out on an Hewlett-Packard (HP) 5890II gas chromatograph with a 30-m 100% methyl silicon narrow bore, fused-silica capillary column interfaced with an HP 5970A mass spectrometer. Helium was the carrier gas. The sample molecules were identified by total ion monitoring and quantified by selective ion monitoring of m/z 183 and 197. The calibration curve was linear to 4 mg/L. The limit of quantification was 0.04 mg/L, and the analytical recovery was approximately 97%. The within-day and between-day imprecision (CV) was <6% and 9%, respectively. In a preliminary study of 12 children, the BU areas under the BU-time curve were 616-949 micromol. min/L after the first dose and 793-1143 micromol. min/L after the fifth dose. We conclude that the GC-MS procedure is suitable for routine analysis of plasma BU.

摘要

白消安(BU)是一种广泛用于抗肿瘤治疗和骨髓消融以准备进行骨髓移植(BMT)的烷化剂。高剂量白消安通常能成功完成预处理且复发率低,但与肝静脉闭塞病有关。我们建立了一种通过气相色谱 - 质谱碎片分析法测定给药后血浆白消安浓度的方案,试图将临床结果与血浆白消安浓度相关联。我们使用非同位素的普舒凡作为内标。萃取到乙酸乙酯中后,白消安和普舒凡分别被碘化为1,4 - 二碘丁烷和1,5 - 二碘戊烷。气相色谱 - 质谱(GC - MS)分析在配备30米100%甲基硅窄孔熔融石英毛细管柱的惠普(HP)5890II气相色谱仪上进行,该色谱柱与HP 5970A质谱仪相连。氦气作为载气。通过全离子监测鉴定样品分子,并通过对m/z 183和197的选择性离子监测进行定量。校准曲线在4 mg/L范围内呈线性。定量限为0.04 mg/L,分析回收率约为97%。日内和日间不精密度(CV)分别<6%和9%。在对12名儿童的初步研究中,首次给药后白消安 - 时间曲线下面积为616 - 949微摩尔·分钟/升,第五次给药后为793 - 1143微摩尔·分钟/升。我们得出结论,GC - MS方法适用于血浆白消安的常规分析。

相似文献

1
Routine analysis of plasma busulfan by gas chromatography-mass fragmentography.采用气相色谱 - 质谱碎片分析法对血浆白消安进行常规分析。
Clin Chem. 1998 Dec;44(12):2506-10.
2
Gas chromatographic-mass spectrometric quantitation of busulfan in human plasma for therapeutic drug monitoring: a new on-line derivatization procedure for the conversion of busulfan to 1,4-diiodobutane.用于治疗药物监测的人血浆中白消安的气相色谱-质谱定量分析:一种将白消安转化为1,4-二碘丁烷的新型在线衍生化方法。
J Pharm Biomed Anal. 2014 Mar;90:207-14. doi: 10.1016/j.jpba.2013.12.004. Epub 2013 Dec 14.
3
Quantification of busulfan in plasma by gas chromatography-mass spectrometry following derivatization with tetrafluorothiophenol.
J Chromatogr B Biomed Sci Appl. 1998 May 8;709(1):47-56. doi: 10.1016/s0378-4347(98)00019-x.
4
High-Throughput Validated Method for the Quantitation of Busulfan in Plasma Using Ultrafast SPE-MS/MS.使用超快速固相萃取-串联质谱法定量血浆中白消安的高通量验证方法。
Ther Drug Monit. 2015 Jun;37(3):319-24. doi: 10.1097/FTD.0000000000000159.
5
Development and validation of a liquid chromatography-tandem mass spectrometry assay to quantify plasma busulfan.一种用于定量血浆白消安的液相色谱-串联质谱分析方法的开发与验证
Ther Drug Monit. 2014 Apr;36(2):169-74. doi: 10.1097/01.ftd.0000443060.22620.cd.
6
Tandem mass spectrometry method for the quantification of serum busulfan.用于定量测定血清中白消安的串联质谱法。
Ther Drug Monit. 2005 Oct;27(5):625-9. doi: 10.1097/01.ftd.0000173372.04945.7b.
7
Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term Performance.用于儿科患者治疗的白消安治疗药物监测:方法的交叉验证及长期性能
Ther Drug Monit. 2018 Feb;40(1):84-92. doi: 10.1097/FTD.0000000000000468.
8
A novel method for quantification of sulfolane (a metabolite of busulfan) in plasma by gas chromatography-tandem mass spectrometry.一种通过气相色谱-串联质谱法定量检测血浆中环丁砜(白消安代谢物)的新方法。
Anal Bioanal Chem. 2012 Oct;404(6-7):1831-8. doi: 10.1007/s00216-012-6330-y. Epub 2012 Aug 24.
9
Sensitive and rapid quantification of busulfan in small plasma volumes by liquid chromatography-electrospray mass spectrometry.通过液相色谱-电喷雾质谱法对小体积血浆中白消安进行灵敏且快速的定量分析。
Clin Chem. 2001 Aug;47(8):1437-42.
10
Busulphan level and early mortality in thalassaemia patients after BMT.
Bone Marrow Transplant. 1999 Feb;23(4):307-10. doi: 10.1038/sj.bmt.1701584.

引用本文的文献

1
New approach to busulfan dosing in infants and children based on a population pharmacokinetic analysis.基于群体药代动力学分析的婴幼儿白消安给药新方法。
Cancer Chemother Pharmacol. 2025 Feb 11;95(1):32. doi: 10.1007/s00280-025-04757-w.
2
Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Plasma Busulfan.液相色谱-串联质谱法测定血浆中白消安的浓度
Methods Mol Biol. 2024;2737:133-140. doi: 10.1007/978-1-0716-3541-4_13.
3
Development and Validation of a Novel LC-MS/MS Method for a TDM-Guided Personalization of HSCT Conditioning with High-Dose Busulfan in Children.
一种用于儿童大剂量白消安造血干细胞移植预处理的TDM指导个体化治疗的新型LC-MS/MS方法的开发与验证
Biomedicines. 2023 Feb 11;11(2):530. doi: 10.3390/biomedicines11020530.
4
Therapeutic salivary monitoring of IV busulfan in patients undergoing hematopoietic stem cell transplantation: a pilot study.造血干细胞移植患者 IV 布美他尼治疗性唾液监测:一项初步研究。
Bone Marrow Transplant. 2017 Oct;52(10):1384-1389. doi: 10.1038/bmt.2017.142. Epub 2017 Jul 24.
5
Population pharmacokinetics of busulfan in pediatric and young adult patients undergoing hematopoietic cell transplant: a model-based dosing algorithm for personalized therapy and implementation into routine clinical use.接受造血细胞移植的儿科和年轻成年患者中白消安的群体药代动力学:一种基于模型的给药算法,用于个性化治疗并应用于常规临床实践。
Ther Drug Monit. 2015 Apr;37(2):236-45. doi: 10.1097/FTD.0000000000000131.
6
Effect of weight and maturation on busulfan clearance in infants and small children undergoing hematopoietic cell transplantation.体重和成熟度对接受造血细胞移植的婴儿和幼儿中白消安清除率的影响。
Biol Blood Marrow Transplant. 2013 Nov;19(11):1608-14. doi: 10.1016/j.bbmt.2013.08.014. Epub 2013 Sep 9.
7
Glutathione S-transferase A1 genetic variants reduce busulfan clearance in children undergoing hematopoietic cell transplantation.谷胱甘肽S-转移酶A1基因变异降低接受造血细胞移植儿童的白消安清除率。
J Clin Pharmacol. 2008 Sep;48(9):1052-62. doi: 10.1177/0091270008321940. Epub 2008 Jul 17.
8
Quantification of busulfan in saliva and plasma in haematopoietic stem cell transplantation in children : validation of liquid chromatography tandem mass spectrometry method.儿童造血干细胞移植中唾液和血浆中白消安的定量分析:液相色谱串联质谱法的验证
Clin Pharmacokinet. 2006;45(3):305-16. doi: 10.2165/00003088-200645030-00006.